☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Kala Pharmaceuticals' Eysuvis (loteprednol etabonate ophthalmic suspension) Receives US FDA's Approval for Dry Eye Disease
October 27, 2020
Jazz Pharmaceuticals Acquires SpringWorks' FAAH Inhibitor Program for Post-Traumatic Stress Disorder
October 27, 2020
Samsung Bioepis Reports Results of Renflexis (biosimilar- infliximab) from Two Studies in IBD Patients
October 27, 2020
Sanofi and Regeneron Report Results of Dupixent (dupilumab) in Part A of P-lll Study for Eosinophilic Esophagitis (EoE)
October 27, 2020
Novartis Presents Results of Iptacopan (LNP023) in P-ll Study for C3 Glomerulopathy at ASN Annual Meeting 2020
October 27, 2020
CStone Signs an Out-Licensing Agreement with EQRx for Sugemalimab and CS1003
October 27, 2020
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions